Skip to content
  • Sunday, 26 July 2026
  • 4:34 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The Inaugural EU Joint Clinical Assessment: Ojemda Sets Precedent Amidst Access Uncertainties
Pharmaceutical R&D

The Inaugural EU Joint Clinical Assessment: Ojemda Sets Precedent Amidst Access Uncertainties

Teuku Ryan Jul 20, 2026 0

The European Union’s landmark Joint Clinical Assessment (JCA) for Ipsen’s orphan-designated drug Ojemda (tovorafenib) has been published, marking a significant…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha Jun 20, 2026 0

In recent years, the pharmaceutical industry has witnessed a dramatic acceleration in the adoption of New Approach Methodologies (NAMs) for…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha May 31, 2026 0

The rapid acceleration in the adoption of New Approach Methodologies (NAMs) for drug safety testing, often perceived as a sudden…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha May 21, 2026 0

The landscape of drug safety testing is undergoing a profound transformation, marked by the rapid ascent of New Approach Methodologies…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha May 14, 2026 0

In recent years, the landscape of drug safety testing has undergone a profound transformation, marked by the rapid acceleration of…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha May 7, 2026 0

The rapid acceleration of New Approach Methodologies (NAMs) in drug safety testing has, for many, appeared to be a sudden…

Read More
Pharmaceutical R&D

The Joint Clinical Assessment: Navigating Procedural and Methodological Hurdles in EU Drug Evaluation

Teuku Ryan May 3, 2026 0

The advent of the Joint Clinical Assessment (JCA) process in the European Union, designed to harmonize the clinical evaluation of…

Read More
Clinical Diagnostics & Pathology

Breath-Based VOC Analysis Emerges as a Rapid, Non-Invasive Frontier for Gut Microbiome Assessment and Early Disease Detection

Reynand Amr Wu Apr 15, 2026 0

A groundbreaking study led by researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia has identified a…

Read More
Clinical Diagnostics & Pathology

Breath-based VOC Analysis Offers Faster, Non-invasive Assessment of Gut Microbiome Health and Earlier Disease Detection

Reynand Amr Wu Apr 6, 2026 0

A groundbreaking study conducted by researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia has identified a…

Read More
Clinical Diagnostics & Pathology

New digital assessment helps lab leaders identify systemic safety gaps before serious injuries and fatalities occur.

Reynand Amr Wu Mar 20, 2026 0

The National Safety Council (NSC), a leading advocate for workplace safety, has introduced a groundbreaking digital assessment tool designed to…

Read More
Can the heart heal itself? New study says it canUnveiling Cellular "Trade Winds": Oregon Health & Science University Researchers Discover Novel Internal Transport SystemThe Key to Keeping Mangoes Fresh: Hainan University Researchers Uncover Optimal Storage Temperature to Combat SpoilageJohns Hopkins Researchers Uncover Molecular Mechanism Behind Rare Kidney Cancer Driven by Fusion Gene Liquid Droplets
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ